Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Bupropion extended-release for depressive disorders.

Jefferson JW.

Expert Rev Neurother. 2008 May;8(5):715-22. doi: 10.1586/14737175.8.5.715. Review.

PMID:
18457528
2.

Bupropion sustained release: side effect profile.

Settle EC Jr.

J Clin Psychiatry. 1998;59 Suppl 4:32-6. Review.

3.

Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.

Segraves RT, Kavoussi R, Hughes AR, Batey SR, Johnston JA, Donahue R, Ascher JA.

J Clin Psychopharmacol. 2000 Apr;20(2):122-8.

PMID:
10770448
4.

Bupropion sustained release: a therapeutic overview.

Davidson JR, Connor KM.

J Clin Psychiatry. 1998;59 Suppl 4:25-31. Review.

5.

Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Clayton AH.

Expert Opin Pharmacother. 2007 Mar;8(4):457-66. Review.

PMID:
17309340
6.

Bupropion SR in the naturalistic treatment of elderly patients with major depression.

Steffens DC, Doraiswamy PM, McQuoid DR.

Int J Geriatr Psychiatry. 2001 Sep;16(9):862-5.

PMID:
11571765
7.

Bupropion for weight reduction.

Gadde KM, Xiong GL.

Expert Rev Neurother. 2007 Jan;7(1):17-24. Review.

PMID:
17187492
8.

Improving antidepressant adherence.

Nemeroff CB.

J Clin Psychiatry. 2003;64 Suppl 18:25-30. Review.

9.

Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population.

Stang P, Suppapanaya N, Hogue SL, Park D, Rigney U.

Am J Ther. 2007 May-Jun;14(3):241-6.

PMID:
17515697
10.

An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey.

Granger AL, Fehnel SE, Hogue SL, Bennett L, Edin HM.

J Affect Disord. 2006 Feb;90(2-3):217-21. Epub 2005 Dec 15.

PMID:
16360216
11.

Why isn't bupropion the most frequently prescribed antidepressant?

Zimmerman M, Posternak MA, Attiullah N, Friedman M, Boland RJ, Baymiller S, Berlowitz SL, Rahman S, Uy KK, Singer S, Chelminski I.

J Clin Psychiatry. 2005 May;66(5):603-10. Review.

PMID:
15889947
12.

Conversion from sustained-release to immediate-release bupropion: patient tolerability and economic impact.

Mayo JL, Cahill GM, Lott RS.

Pharmacotherapy. 2005 Apr;25(4):520-5.

PMID:
15977913
13.

Efficacy of sustained-release bupropion in neuropathic pain: an open-label study.

Semenchuk MR, Davis B.

Clin J Pain. 2000 Mar;16(1):6-11.

PMID:
10741812
14.

Bupropion: pharmacology and therapeutic applications.

Foley KF, DeSanty KP, Kast RE.

Expert Rev Neurother. 2006 Sep;6(9):1249-65. Review.

PMID:
17009913
15.

Bupropion slow-release response in depression: diagnosis and biochemistry.

Goodnick PJ, Dominguez RA, DeVane CL, Bowden CL.

Biol Psychiatry. 1998 Oct 1;44(7):629-32.

PMID:
9787888
16.

Bupropion sustained release. A therapeutic review of Zyban.

Zwar N, Richmond R.

Aust Fam Physician. 2002 May;31(5):443-7. Review.

PMID:
12043548
17.

Perceptual disturbances associated with low-dose bupropion sustained-release treatment.

Liu CY, Chien YS.

J Clin Psychopharmacol. 2007 Oct;27(5):543-4. No abstract available.

PMID:
17873707
18.

The treatment of depression with different formulations of venlafaxine: a comparative analysis.

Olver JS, Burrows GD, Norman TR.

Hum Psychopharmacol. 2004 Jan;19(1):9-16. Review.

PMID:
14716706
19.

Bupropion: a review of its use in the management of major depressive disorder.

Dhillon S, Yang LP, Curran MP.

Drugs. 2008;68(5):653-89. Review. Erratum in: Drugs. 2008;68(7):980.

PMID:
18370448
20.

Supplemental Content

Support Center